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ABSTRACT 
 
Title 
Cases of occupational asthma assessed at the National Institute for Occupational Health 
Occupational Medicine Clinic from 1997 to 2007. 
 
Background  
Occupational asthma is one of the most commonly reported occupational respiratory diseases 
in industrialized countries. Literature suggests that about 15% of all adult-onset asthma is 
caused by workplace exposures. It is potentially preventable and the prognosis is good with 
early diagnosis and adequate treatment. However, occupational asthma is under-diagnosed 
and under-reported. Identification of common causative agents and employment of 
preventative measures are necessary for proper management and control. 
 
Objectives 
1. To characterize occupational asthma cases assessed at NIOH Occupational Medicine 
Clinic from 1st January 1997 to 31st December 2007 in terms of:  
• types of industries, occupations and agents 
• duration of exposure prior to onset of occupational asthma 
• time from onset of symptoms to diagnosis 
• nature of exposure e.g. intermittent, daily, etc. 
2. To investigate factors influencing latency period in cases of sensitizer-induced asthma 
3. To investigate factors influencing lag time to diagnosis in cases of sensitizer-induced 
asthma   
 
 
Methods 
A record review of a series of cases of occupational asthma was done. All cases of occupational 
asthma diagnosed from 1st January 1997 to 31st December 2007 by NIOH doctors were 
identified from the Clinic’s electronic database. All the records of patients who had a final 
diagnosis of occupational asthma were assessed using a standard data capture sheet. Doubtful 
cases were presented at the NIOH Occupational Medicine clinical discussion meeting for a 
consensus decision as to whether they qualified to be included in the study or not. Ethical 
approval was granted by the University of the Witwatersrand Human Research Ethics 
Committee (Medical). 
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Results 
One hundred and forty two cases of occupational asthma were identified. Of these, 131 were 
sensitizer-induced and 11 were irritant-induced asthma. Low molecular-weight agents were in 
the majority with isocyanates, welding fumes, vanadium being the most common. Within the 
high molecular weight category, wheat was the most common. The majority of cases emanated 
from the Engineering, Chemical, Smelter and Food industries. Latency period from first 
exposure to development of symptoms was surprisingly long: a mean of 9.8 years and a 
median of seven years. The time from onset of symptoms to diagnosis was also long (mean of 
4.9 years and median of three years). Younger cases had a shorter latency period and a longer 
delay in diagnosis. Agents and jobs for irritant-induced asthma cases varied widely and some 
came from unexpected industries.    
 
Discussion 
This review of asthma referrals to the NIOH Occupational Medicine Clinic has highlighted 
causative industries and identified exposure agents implicated in cases of occupational asthma. 
The very wide range of industries, occupations and agents associated with these cases is 
suggestive of a wide-spread occupational asthma problem in the region referring cases to the 
Clinic. The long latency period and delay in diagnosis are of concern since prompt diagnosis 
and removal from exposure is associated with a better prognosis. Irritant-induced asthma is 
infrequently reported in the local literature, but the range of agents and jobs is possibly 
indicative of under-diagnosis.    
 
Conclusion 
Occupational asthma is potentially preventable. New cases still arise particularly in poorly 
controlled workplaces which are capable of employing basic measures to control exposures. 
Medical surveillance, prompt diagnosis, proper medical management and application of 
workplace preventative measures are essential in decreasing the burden of disease and 
impairment. 
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
 
In this chapter, work-related asthma is defined. A distinction is made between the types of 
occupational asthma. The public health importance of occupational asthma and the 
socioeconomic consequences for workers diagnosed with the disease are highlighted. Briefly, 
the National Institute for Occupational Health (NIOH) Occupational Medicine Clinic – the Clinic 
which is the source of study subjects, is described. Common industries, occupations and agents 
responsible for the majority of cases of occupational asthma are described based on literature 
from population studies, surveillance programmes and case series published globally and 
locally. A brief overview of studies of occupational asthma prognosis (health outcomes) is done 
and the chapter ends with the aims and objectives of this study. 
  
Asthma caused by work (occupational asthma) is the most commonly reported occupational 
respiratory disease in industrialized countries and it is fast approaching pneumoconiosis in 
developing countries.1 Several studies looking at the proportion of adult-onset asthma cases 
attributable to work exposures indicate that about 15% of all adult-onset asthma is caused by 
workplace exposures.2-6 
 
This growing recognition of the importance of occupational asthma warrants exploration of 
preventive strategies. Primary prevention requires the identification of occupational exposures 
in terms of agents, jobs and industries associated with such exposures, so that interventions to 
control exposure can be prioritized. Such strategies have had some success in high-income 
countries.7 One means of identifying the common causes of occupational asthma is to review 
the exposure histories of cases presenting to referral clinics. 
 
Additionally, in developing countries, there is incomplete knowledge of asthma -causing agents 
particularly as the number of new agents introduced in many workplaces increases. There is a 
possibility of new causes of occupational asthma emerging from unstudied workplaces; 
justifying identification of agents in a group of workers from different industries. Therefore, a 
case series study of patients from a variety of industries provides the opportunity to identify 
such settings for preventive strategies.  
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1.1 BACKGROUND 
 
1.1.1 Work-related asthma and occupational asthma  
 
Work-related asthma is a broad term that includes asthma caused by workplace exposures 
(that is, occupational asthma) as well as pre-existing asthma made worse by work exposures 
(work-exacerbated asthma).8 Two types of occupational asthma are distinguished by whether 
they appear after a latency period. Sensitizer-induced asthma appears after a latency period of 
exposure necessary for the worker to acquire sensitization to the causal agent. This type 
includes occupational asthma that is induced by an IgE mechanism (most high- and some low-
molecular-weight agents), and occupational asthma in which an IgE mechanism has not been 
demonstrated consistently (low-molecular-weight agents, such as diisocyanates, western red 
cedar and acrylates). On the other hand, irritant- induced asthma is characterized by the 
absence of a latency period. It occurs after accidental exposure to high concentrations of a 
workplace irritant and symptoms occur within 24 hours following exposure. This clinical entity 
used to be known as Reactive Airway Dysfunction Syndrome (RADS). The pathophysiologic 
mechanism underlying irritant-induced asthma is not well understood, and it is not known why 
the asthmatic response persists in certain individuals.9-12  
 
Controversy still exists about whether intermittent moderate-level exposure and chronic low-
level exposure to irritants can cause irritant-induced asthma. Both possibilities are 
legitimate.13, 14 However, because there is no consensus yet, only the typical irritant induced 
asthma from one-time high exposure to an irritant (RADS) has been considered in this study. 
 
1.1.2 Burden of occupational asthma in South Africa 
 
South Africa does not have a surveillance scheme or register for recording occupational 
diseases; as such the incidence and prevalence of occupational asthma in South Africa is not 
known. A few studies done in different workplaces have reported estimated prevalences and 
incidences although comparison among them is difficult because of different definitions of 
asthma and diagnostic methods used.1   
In the same paper, the authors presented a table of South African studies with prevalence 
ranging from 3% in wood working operations to a high cumulative incidence of 41% in 
platinum refinery workers. Those studies that reported a low prevalence15 attributed it to 
under-recognition and lack of occupational health surveillance programmes in small 
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workplaces. The Surveillance of Work-related and Occupational Respiratory Diseases in South 
Africa (SORDSA) programme 1999 report identified occupational asthma as the second most 
common occupational respiratory disease in South Africa after pneumoconiosis.16 Since the 
collapse of SORDSA, there is no nationwide data available to describe the distribution or causes 
of work-related respiratory diseases in South Africa; as such, targeting intervention is a 
challenge. However, statistics from the NIOH Occupational Medicine Referral Clinic’s annual 
report, 17 shows occupational asthma as the most frequently assessed occupational disease in 
the Clinic. This information, although not nationally representative, provides an opportunity to 
describe cases of occupational asthma assessed at this Clinic. 
 
1.1.3 Socioeconomic impact of occupational asthma 
 
Occupational asthma often affects young and economically active patients. This chronic 
condition is a cause of morbidity and affects quality of life and future employment, and may 
lead to loss of income.18 
Avoidance of exposure to the causative agent is one part of management of sensitizer induced 
asthma that has shown to significantly improve symptoms and offers the best chance for 
recovery. However, in many instances, control of workplace exposures is not possible and 
workers have to be relocated or resign, with uncertain prospects of future employment. This is 
particularly true of many small workplaces without alternative areas free of exposure to the 
causal agent or other triggers. The result is job and income loss for affected workers. 
 
Studies that have investigated the socioeconomic impact of occupational asthma have 
consistently found deterioration in the socio economic status of a high proportion of patients; 
be it through job loss, demotion, limitations in doing daily activities or frequent absenteeism 
from work. The study by Ameille et al. recorded an average decline in income of more than 
50% in those people who were removed from their jobs as opposed to about 20% income loss 
in those who remained in their current employment.18-23   
Although compensation under South African legislation covers medical costs, including visits to 
general practitioners and hospitalization, the monetary compensation does not match previous 
income (Compensation for Occupational Injuries and Diseases Act No. 130 of 1993). At times 
patients suffer financial losses while waiting for compensation outcome, which can take more 
than a year. The situation in South Africa (as opposed to many developed countries) is further 
complicated by failure of the compensation system to compensate for loss of income and 
retraining for other jobs within or outside the company. A high unemployment rate with many 
workers being unskilled labourers with limited formal education adds to the socio-economic 
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burden. It is not uncommon to find some workers opting to remain in exposed jobs for financial 
reasons. This however, leads to deterioration in health.24 Compensation systems that aim at 
retraining, rehabilitation and relocation rather than paying for impairment might be effective in 
positively changing the socioeconomic outcomes of occupational asthma.25  
 
1.1.4 Primary prevention and prognosis 
 
Unlike most other forms of asthma, occupational asthma is potentially preventable by 
controlling workplace exposures.26 One Canadian study3 concluded that the removal of 
exposure to known inducers could prevent as much as 18% of adult-onset asthma in that 
country. Another study, by Ameille et al.,27 showed that early removal from exposure is 
important for treatment and preventing persistent disease. Reducing or eliminating exposure to 
the offending agent will usually reduce the severity of symptoms or, in some cases of early 
intervention, it may eliminate symptoms completely. Persons who remain exposed are more 
likely to have persistent and troublesome asthma.  
 
The most important aspect of the definition of occupational asthma is evidence of a direct 
causal relationship between workplace exposures and development of asthma. 28 Knowledge 
and understanding of these asthma-causing agents is important for primary prevention of 
occupational asthma through exposure control. Several studies 29-31 have outlined ways to 
prevent the occurrence of occupational asthma by controlling the exposures because the risk of 
developing occupational asthma is determined less by individual susceptibility (atopy, smoking, 
HLA phenotype) and more by the level of exposure to its causes. In general, the higher the 
exposure, the greater the risk and by implication, lowering the level of exposure reduces the 
incidence of disease.30 
 
There are over 300 agents known to cause occupational asthma.32, 33 It is important to identify 
these agents as management and outcome may differ depending on the type of agent a worker 
is exposed to. For example, exposure to a sensitizer generally warrants complete removal from 
exposure whereas reducing workplace exposure to respiratory irritants and environmental 
allergens; limiting exposure to non-occupational irritants such as tobacco smoke; optimizing 
anti-asthma therapy, educating the patient on the usage of the drugs, and emphasizing the 
importance of compliance often allow workers with irritant induced asthma to continue working 
in the same job.  However, these measures are not sufficient to prevent the relapse of 
sensitizer induced asthma as even minute amounts can evoke a reaction severe enough to 
cause major clinical consequences. Although one of the challenges in prevention is the fact that 
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there are several hundred known agents arising from many occupations in most major 
industries, identification and control of such agents is still possible.34  
 
Companies without established medical services lack capacity to identify agents and conduct 
medical surveillance which leads to delay in the diagnosis of occupational asthma. Patients 
diagnosed late, do poorly as their disease is more severe at the time of diagnosis; hence the 
importance of early diagnosis and early removal from the offending agent.   
 
From a public health point of view, it is important to identify industries, jobs and agents 
causing occupational asthma because this can lead to targeted intervention. In industries 
where there is a known risk to workers, steps can be taken to eliminate or at least reduce the 
number of workers who will be affected.  
 
1.1.5 The NIOH Clinic 
 
The NIOH has run a referral Occupational Medicine Clinic since 1972.35 The Clinic receives 
referrals from within South Africa (particularly Gauteng and Mpumalanga) and neighbouring. 
Kwa-Zulu Natal, Western Cape and Free State provinces run similar occupational medicine 
clinics but on a smaller scale, hence only complicated cases from these provinces are referred 
to NIOH. Patients are referred by a select group of medical practitioners and nurses seeking 
confirmation of the diagnosis or assistance with submission of compensation claims. Cases 
referred here are either asthma cases for confirmation of occupational asthma or as probable 
asthma for further diagnostic work up at the Clinic. Cases come from a variety of industries but 
there are industries important in occupational asthma that are not within the vicinity of the 
NIOH e.g., platinum refining. As such, cases from these industries rarely present to the NIOH 
Clinic. 
The majority of the patients referred to the clinic suffer from occupational lung diseases. These 
include, but are not limited to, pneumoconioses, occupational asthma, tuberculosis, chronic 
obstructive pulmonary disease (COPD) and occupational lung cancers. Each year on average 
the Clinic assesses approximately 220 cases and about 20% are occupational asthma cases. 
For many years, occupational asthma was the second most common occupational lung disease 
assessed in the Clinic. But in the past two years, occupational asthma has become the most 
commonly assessed lung disorder.36 
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The NIOH Clinic, because it assesses cases in and around Gauteng, is an important source of 
occupational asthma cases and therefore can provide a means of identifying industries, jobs 
and agents in the catchment area for targeted prevention. 
 
 
1.2 LITERATURE REVIEW 
 
1.2.1 Industries, jobs and agents in occupational asthma 
 
There are over 300 agents known to cause occupational asthma.32, 33 Exposure agents can be 
categorized crudely into high molecular weight (HMW) and low molecular weight (LMW). The 
high-molecular-weight compounds are typically animal and plant derived proteins or 
polysaccharides such as wheat flour and animal dander that cause an IgE-dependent immune 
response. The low-molecular-weight compounds include organic and inorganic compounds that, 
with a few exceptions, are not associated with an IgE mechanism, but are chemicals that can 
also initiate an immune response after repeated inhalation. These agents can cause 
sensitization through a hapten-mediated effect. The nature of the immune response is more 
complex for the low-molecular-weight chemicals than it is for the high-molecular-weight 
agents.  
 
1.2.1.1 Global causes of occupational asthma: international studies 
                                                                                                                                                              
A: Population studies 
 
Although results from population studies are valid for the specified population, there are some 
similarities across populations particularly in industries with similar jobs and exposures 
allowing for comparisons. The strength of population-based studies is the inclusion of 
occupational asthma workers who have left the workplace rather than only those who are 
currently exposed, thus giving a more complete picture and reducing the healthy-worker 
effect.30 They will, however, be influenced by the nature of industries dominant in the regions 
of the surveyed populations. 
There is a lack of general population-based epidemiological studies assessing agents related to 
work- related asthma.37 The few that have examined the relationship between occupational 
exposures and asthma have managed to report generally about exposures and not specific 
chemicals or dust types.38-40 
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The majority of population studies have reported on the risk of asthma in different occupational 
groups.  These studies do not lend themselves to comparison because methodologies and case 
definitions are not similar across studies. Some studies defined asthma based on evidence of 
bronchial hyper responsiveness, while others collected information on subjective account of 
asthma symptoms and medication used. Therefore, there is a possibility of misclassification of 
adult onset asthma as occupational asthma hence such studies need to be followed up by 
epidemiological studies of assessment of exposures and elevated risks in these occupational 
groups and industries. Results from some population studies looking at risk of developing 
asthma in certain occupational groups are presented below. The risk varies depending on the 
geographical location and dominant industries in that population or community. 
  
In Singapore, the risk was elevated for service workers, cleaners, textile workers, garment 
makers, electronic production workers, printers, construction or renovation workers and 
manufacturing related workers.41  
 
In Spain, the highest risk of asthma in those between 20-44 years of age was observed for 
laboratory technicians, spray painters, bakers, plastics and rubber workers, welders and 
cleaners.42   
 
A New Zealand study identified certain occupations significantly associated with asthmatic 
symptoms and bronchial hyper responsiveness in New Zealand adults aged 20-44 years. The 
highest risk occupations were farmers and farm workers, laboratory technicians, food 
processors (other than bakers), chemical workers and plastic and rubber workers. It is 
surprising that some groups known to be associated with occupational asthma, like bakers and 
spray painters, did not show excess risk in Singapore and New Zealand. The reasons are not 
clear but could be attributed to low numbers in the groups or improved standards of work, thus 
truly reflecting low prevalence.43 
 
A Northern California study that evaluated the role of occupational factors on the prevalence of 
self-reported asthma, chronic bronchitis and asthma-like symptoms among women more than 
54 years of age found high risk in artists, writers, decorators, photographers, social workers 
and homemakers. It must be noted that this is a specific group (women only) and occupational 
exposures were arbitrarily measured by taking only the last job and the longest occupation in 
which a subject was employed. Thus, information on other jobs that may have had exposures 
that could cause asthma was lacking. Common industry in this community is farming (grapes). 
Farm workers as a group did not show a high risk as would have been expected. The reason for 
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this might be the low numbers of women in this industry or less intense exposures in women 
than in men.44       
In Europe and other industrialized countries, authors found high risk in farmers, painters, 
plastic workers, cleaners, spray painters and agricultural workers. The study used a strict 
definition of asthma that included metacholine challenge test, questionnaire on symptoms and 
asthma medication.45    
 
A South Finland population study assessing relationship between occupation and risk of 
developing asthma in adults found an increased risk both in traditional industries and several 
other non-industrial occupations. For men, the risk was increased in bakers, food processors, 
textile workers, painters, construction workers, electrical and electronics production workers, 
laboratory technicians, storage workers, laundry workers, shoemakers and repairers, metal 
plating and coating workers. For women, shoemakers, jewelry engravers, waitresses, cleaners, 
dental workers, molders and bakers were at a high risk of asthma.46 
 
A US population study of the prevalence of asthma by industry reported higher risk in those 
employed in printing, publishing and allied industries for white males. For white females, 
prevalence was elevated in the health care industry. For blacks, prevalence was higher in 
furniture, lumber, wood and entertainment industries. Other industries of importance were 
automobile dealers and gasoline station, durable goods, personal services and sanitary 
services.47 This study showed that asthma prevalence patterns differed by race and sex.  
 
These population studies identified occupational groups and industries associated with high risk 
of development of asthma. This can form the basis for targeted prevention of occupational 
asthma. The advantage of community based studies is that individuals are selected irrespective 
of their current job and the degree of selection bias may be significantly reduced. However, 
methodological challenges are common.  
 
B: Surveillance programmes 
 
Surveillance programmes which rely on specialist physician notification of occupational 
respiratory diseases have been established in some countries because of limitations in many 
sources of occupational diseases data, such as workers’ compensation data.48 The majority of 
these schemes are similar in voluntary reporting methods with a few differences in the 
categories of health care workers reporting to the scheme. Although these programmes rely on 
voluntary reporting of cases which leads to underestimation of incidence and prevalence, and 
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also the unbalanced specialists’ coverage within the same country which indicates variable 
accessibility, they still offer valuable incidence and causation statistics for occupational 
respiratory diseases.49  One such example is the Surveillance of Work-related and Occupational 
Respiratory diseases (SWORD) programme in the United Kingdom, which has been running for 
more than a decade. Data from SWORD has helped identify new agents causing occupational 
asthma and led to these agents being further investigated and controlled.50  
 
The highest incidence rate of occupational asthma was reported in the manufacture of wood 
products and latex. Asthma due to latex was seen in specific groups like laboratory workers, 
shoe workers and healthcare workers.51 
 
The SHIELD (not an acronym) scheme was started in 1989. It is a reporting scheme which only 
studies the general and occupation specific incidence of occupational asthma in the West 
Midlands area of England.48 A publication on the first three years’ results by Gannon et al. 
reported the common agents to be isocyanates, flour and colophony; and the most common 
occupation was spray painters.52  
 
A study by di Stefano et al.53 aiming at estimating the incidence of occupational asthma in the 
West Midlands in 1990-97, found spray painters to be the highest risk occupation, followed by 
electroplaters, rubber and plastic workers, bakery workers and moulders. Isocyanates 
remained the most common causative agent. There was a decrease in reported cases due to 
colophony, flour and wheat. Increasing numbers of latex and gluteraldehyde were also noted. 
A recent publication reported on the 15 years (from 1989 to 2004) of SHIELD noted a decline 
in the number of cases of occupational asthma exposed to latex and gluteraldehyde. This was 
attributed to better control of exposures. Colophony was also declining but there were 
outbreaks due to metals like cobalt and chrome.54 
 
The French Observatoire National des Asthmes Professionnels (ONAP) programme, was set up 
to develop a monitoring system for occupational asthma in France and to promote primary 
prevention based on a better knowledge of the incidence of occupational asthma and its causal 
agents. It is a voluntary reporting system by physicians, mainly occupational and chest 
physicians. The highest incidence rates of occupational asthma in France were observed in 
bakers and pastry makers, hairdressers, car painters and wood workers. The most frequently 
identified agents were flour, isocyanates, latex, aldehyde, persulphate salts and wood dusts.55 
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In the USA, the Sentinel Event Notification System for Occupational Risks (SENSOR) has been 
operating in six states since 1988. The objectives of SENSOR are to identify potentially 
dangerous sentinel cases in the work environment and to subsequently initiate investigations 
and implement interventions. Cases reported must be diagnosed by a physician. The most 
common agents reported in the 1999 report were metal working fluids, cleaning agents and 
isocyanates. Industries where cases of work-related asthma were identified were 
manufacturing (includes food, primary metal, chemical, transport equipment, plastic and 
rubber products manufacturers) and health care and social services.56 This could be attributed 
to under-reporting or more likely to the success of prevention strategies in various workplaces. 
 
In Canada, the first reported programme was from a British Columbia group57 which evaluated 
the feasibility of a surveillance program for occupational respiratory disease based on voluntary 
reporting by physicians. The methods used were similar to the UK’s SWORD project. The 
specialists involved were both respiratory and occupational physicians. In 1991, they reported 
on the first year’s RESULTS. The most common agent thought responsible for occupational 
asthma was plicatic acid from Western Red Cedar, followed by chemicals and isocyanates. The 
higher incidence of Western Red Cedar asthma than that found in other parts of the world was 
thought to be due to the large forest industry in British Columbia. The programme did not 
continue past the pilot stage due to lack of funding.48 
 
The PROPULSE (PROjet PULmonaire SEntinelle) scheme in Quebec58 was also based on the 
UK’s SWORD model with similar reporting procedures and the same diagnostic categories, but 
different participating physicians comprising allergists and respiratory physicians, but no 
occupational physicians. Isocyanates and flour were the most commonly reported agents. 
Although providing useful data, this programme also did not progress past the pilot stage due 
to lack of funding.48 
 
The New Zealand Notifiable Occupational Disease System (NODS) was established in March 
1992. It is a voluntary system whereby occupational physician specialists, general 
practitioners, occupational health nurses, health professionals and individuals can notify a 
health-related condition suspected to have risen from work. The numbers reported were small 
because many practitioners and specialist are unaware of the scheme. However, recognized 
asthma causing agents like isocyanates, remained the most common agents.59 
  
In Australia, a scheme known as SABRE (Surveillance of Australian Workplace-Based 
Respiratory Events) was established in 1997. It is based on voluntary reporting by physicians. 
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Publication of results from the first 3.5 years reported wood dust as the most common agent, 
followed by isocyanates. The incidence of asthma was lower compared to surveillance schemes 
in other countries. The authors attribute this to under-ascertainment of cases, under-diagnosis 
and doctors not willing to report occupational cases due to legal influences, e.g. workers’ 
compensation system.60      
 
The Swedish scheme is a system for registration of workers' own reports and claims about 
occupational asthma as well as other occupational diseases. All claims on occupational diseases 
are listed in the Swedish Register of Reported Occupational Diseases (SRROD). When claiming 
that they have an occupational disease, workers have to complete a form with information 
regarding diagnosis, causes, current workplace and some basic personal information. The claim 
form has to be countersigned by the employer. The validity of asthma diagnosis could not be 
ascertained so over-estimation of asthma could happen. High risk occupations, as in other 
countries, included bakers, chemical processors and plastic workers. High risks were also found 
in occupations with less well recognised risks of asthma, such as welders and foundry workers. 
This may reflect patterns of reporting but a real increased risk cannot be ruled out.61 
 
Industries, occupations and agents reported to these schemes vary by country but there are 
agents common to all. Most common agents are isocyanates (mainly from spray painting), 
flour in bakery workers, latex in health care workers and wood in the manufacturing of wood 
products. On the other hand, countries with specific dominant industries will report specific 
agents associated with these industries. In Finland, the Finland Register of Occupational 
Diseases (FROD) report indicates that almost half of cases of occupational asthma arise in 
agriculture and manufacturing industries. The most common reported agents were animal 
epithelia, flours, grains and fodders.62  
 
Despite likely under-reporting associated with voluntary reporting schemes, they have been 
useful in identifying types of exposures common in cases of occupational asthma and common 
industries where these cases arise. Consistency of common agents and industries across 
countries gives merit to the usefulness of the schemes and provides opportunity for different 
countries to learn from each other strategies of primary prevention in those industries 
identified. 
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 C: Case series 
 
Data on case series of occupational asthma are scarce. Although there have been surveillance 
studies of occupational respiratory diseases and occupational asthma, clinical case series of 
patients suffering from occupational asthma have largely been confined to groups of workers 
reacting to single specified agents.63 A few case series in specific occupational medicine clinics 
have provided data on common industries, jobs and agents causing occupational asthma.  
 
A recent study done in the New York State Occupational Health Clinics found that most patients 
with work-related asthma were employed in service and manufacturing industries. Commonest 
occupations were teachers, farm operators and construction workers; and the most common 
agents implicated in occupational asthma were dust, indoor air, mold and solvents.64 
 
In Washington, a study by Wheeler et al, reported construction, shipbuilding, automotive 
repair, airplane manufacturing, paper and electronics manufacturing as the commonest 
industries that employed cases of occupational asthma. Common occupations included 
painters, plumbers, machine operators, construction labourers, cleaners, cooks, forestry 
workers, carpenters and ship fitters. Agents implicated were isocyanates, solvents, red cedar 
and other wood, corrosive agents, crabs, formaldehyde and welding fumes.65  
 
Patterns of occupations, industries and causative agents differed by geographical location and 
type of industries common in that setting. There is however, more information for potential 
prevention of workplace exposures from identified industries.  
 
1.2.1.2 South Africa 
 
There have been no population studies in South Africa. A Surveillance of work-related and 
Occupational Respiratory Disease scheme (SORDSA) in South Africa has been a source of data 
for distribution and causes of work-related respiratory diseases until its demise in 2003. 
SORDSA was established in 1996. It was a national database with uneven reporting among 
provinces. Participating reporters were pulmonologists and occupational medicine practitioners. 
To increase information dissemination and overcome underreporting, occupational health 
nurses were added as reporters.  This brought about questions as to the validity of diagnoses 
made by occupational health nurses. However, information on common agents and industries 
was still useful in describing the nature and extent of work-related respiratory diseases in 
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South Africa. In a report of the first two years66 latex was the most frequently reported agent, 
followed by isocyanates and platinum salts. 
  
Although there are few studies of occupational asthma in South Africa, a comprehensive but 
not exhaustive list of causative agents published by SORDSA, though slightly out of date, 
covers most common agents. A report covering the years 1997-1999 identified the most 
common asthma causing agents to be isocyanates, latex proteins, flour, grain and platinum 
salts.67 The scheme had to be abandoned in 2002 due to lack of reporting. Other South African 
studies have reported occupational asthma in grain mill workers,68-70 small bakeries in 
supermarkets,71 health care workers exposed to latex 67, 72 and soybean workers.73 Studies 
conducted in the seafood processing industry74 identified allergens such as crab, prawn, 
shrimp, soya, anisakis and salmon in cases of occupational asthma. In poultry workers 
sensitization was confirmed to chicken feed, litter and faeces.75 Spider mite allergy was 
responsible for work-related asthma symptoms in table grape farm workers; 76 and Locusta 
migratoria was found as a potent sensitizer in those exposed to migratory grasshopper.77  
 
 A high prevalence due to isocyanates was found in chemical processing plant78 and in 
automotive spray painting.79 In precious metal refineries, a 41% incidence of platinum salt 
sensitivity was reported in platinum refinery80 (compared to 11% cumulative incidence in a 
vanadium plant), although the diagnostic criteria for occupational asthma relied on symptoms, 
a less strict measure.81 A prevalence of between 3% and 7% was found in those exposed to 
wood dust (hardwood and softwood) in a furniture plant and sawmill plant respectively.82 
    
Although studies employed different methodology and exposure assessment was crude, the 
data on causative agents are still valuable in terms of identifying industries for intervention. 
 
1.2.2 Occupational asthma prognosis 
 
As socioeconomic outcomes of occupational asthma have been discussed already, only health 
outcomes will be discussed here. The prognosis of occupational asthma depends largely on 
cessation of exposure to the offending agent, duration of exposure to sensitizers after 
symptom onset and severity of asthma at diagnosis.20, 21, 28, 83  
 
Several studies that have shown that cessation of exposure led to better health outcomes have 
also highlighted workplace challenges in attaining exposure avoidance either by elimination of 
the exposure or by relocation of the affected worker. The reality is that in most instances, 
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diagnosis is delayed and workers start treatment late when the disease is so severe that 
complete recovery may not be attained. Once diagnosed, removal from exposure is beneficial 
in terms of symptoms and lung function improvement. However, it may not be practical to 
relocate workers in many workplaces and even if that could be arranged, there might be loss of 
income from position downgrade or from not being able to do overtime anymore. Fear of losing 
income may lead workers to opt to remain in exposed occupations particularly where 
compensation is inadequate to meet the financial loss. The focus should be on cessation or 
reduction of exposure and on early recognition of occupational asthma (early diagnosis) to 
start medical therapy as soon as possible; because outcome is better in workers who have 
shorter duration of symptoms before diagnosis.84-87  
 
Reduction of exposure necessitates identification of exposure agents and specific industries in 
cases of occupational asthma, hence this study that aims to identify agents and industries 
implicated in cases of occupational asthma in cases referred to the NIOH Clinic. 
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1.3 Study aims and objectives 
 
1.3.1  Aim 
 
To describe cases of occupational asthma assessed at the Clinic from 1st January 1997 to 31st 
December 2007. 
 
1.3.2 Objectives  
 
1. To characterize occupational asthma cases assessed at NIOH Occupational Medicine 
Clinic from 1st January 1997 to 31st December 2007 in terms of:  
4. types of industries, occupations and agents 
5. duration of exposure prior to onset of occupational asthma 
6. time from onset of symptoms to diagnosis 
7. nature of exposure e.g. intermittent, daily, etc 
2. To investigate factors influencing latency period in cases of sensitizer-induced asthma 
3. To investigate factors influencing lag time to diagnosis in cases of sensitizer-induced 
asthma   
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CHAPTER TWO: MATERIALS AND METHODS 
 
In this section, the study design and method of selection of participants are described. Detailed 
descriptions of case definitions with criteria for inclusion into the study and data management 
are outlined. The chapter ends with ethical issues related to the study.    
 
2.1 STUDY DESIGN 
 
This is a descriptive study of cases of occupational asthma assessed by Clinic doctors at the 
NIOH Occupational Medicine Clinic from 1997 to 2007.  
2.2 STUDY POPULATION AND SAMPLING (APPENDIX A) 
 
All possible cases of occupational asthma diagnosed from 1st January 1997 to 31st December 
2007 by NIOH doctors were identified from the Clinic’s database. The Clinic has an electronic 
database of cases assessed at the Clinic since 1991. Data captured in the database includes 
patient’s demographic data, referrer’s details, occupational history, medical history including 
medical investigations, final diagnosis and compensation submission information. The database 
enables one to trace a patient based on South African identity number or passport number for 
foreign nationals and name and surname. Cases were identified by searching the database for 
cases which had a preliminary diagnosis of occupational asthma for the years 1997 to 2007. 
Search terms included, asthma, occupational asthma, irritant-induced asthma, RADS, Reactive 
Airway Dysfunction Syndrome, Bronchitis, COPD, Chronic Obstructive Airway Diseases and 
Chronic Obstructive Pulmonary Diseases. The following additional information was extracted 
from the database: identification number, name, surname, clinic unique number, year of 
diagnosis and occupational diagnosis. A total of 730 records were identified. Of these, one 
hundred and fifty seven (157) cases were identified as possibly having occupational asthma. 
Because the database contains selected information only, medical records (files) of 157 
identified cases were retrieved to get comprehensive exposure information. Seventeen (17) 
doubtful cases were presented at the NIOH Occupational Medicine clinical meeting for a 
consensus decision as to whether they qualified to be included in the study. The panel was 
made up of 3 occupational medicine practitioners with more than 5 years’ experience in 
occupational medicine. For consistence, the same panel decided on all cases. The panel 
accepted a further two cases from the doubtful group. The final number of cases included in 
the database was 142. Appendix 1 shows the process of selection of these cases. 
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Exclusion criteria 
 
Of the 157 cases, 15 were excluded because:  
• The case had pre-existing asthma aggravated by workplace exposures, i.e.  work-
exacerbated asthma, or 
• There was no objective evidence of asthma, or 
• The case was not resolved because of loss to follow-up, or 
• The exposure agent was not an established cause of occupational asthma, or 
• The case was exposed to long term low-dose irritants, thus not fulfilling the inclusion 
criterion of a once-off high exposure to respiratory irritants. 
Thus 142 cases were left for study. These were divided into sensitizer and irritant- induced 
cases as shown below. 
 
Sensitizer- induced asthma 
 
Of the total 142 confirmed cases of occupational asthma, 131 had a convincing diagnosis of 
sensitizer-induced asthma based on medical records showing: 
• Objective evidence of asthma as defined by reversible airflow limitation or supported by 
a positive metacholine challenge test showing non-specific bronchial hyper 
responsiveness. In this Clinic, a rather specific approach of a post-bronchodilator 
change in FEV1 of 15% (as opposed to 12% recommended by South African Thoracic 
Society) or more and 200ml was considered significant. The 15% criterion was used 
previously as a diagnostic criterion hence maintained its usage for consistency. A 
metacholine challenge test was considered positive when a fall of 20% in FEV1 was 
induced by a concentration of 8mg/ml or less   
• Confirmed workplace exposure to an established cause as listed by Chan-Yeung et al. 
(2006).33 Temporal association with work i.e. development of asthma after exposure to 
a particular agent encountered in the workplace and presence of symptoms related to 
exposure  
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Irritant-induced asthma 
 
Eleven (11) cases were considered irritant induced asthma as they satisfied the following 
criteria according to the American College of Chest physicians’ consensus statement.28 
 
• Absence of pre-existing asthma symptomatology, or a history of asthma in remission 
and exclusion of conditions that can simulate asthma 
• Acute onset of asthma following a single once-off very high exposure to workplace 
irritants 
• Exposure is to an irritant vapor, gas, fumes, or smoke in very high concentrations 
• The onset of asthma symptoms develops within minutes to hours and < 24 hours after 
exposure 
• There is a positive metacholine challenge test finding or equivalent, which signifies 
hyperactive airways  
• There may or may not be airflow obstruction confirmed with pulmonary function testing 
• There is exclusion of another pulmonary disorder that explains the symptoms and 
findings 
 
Occupations and industries were categorized according to a known standard classification 
lists.88 Industry classification system used was a standard system from the Compensation Fund 
in Pretoria. The classification list uses a rating system dividing employers into 23 classes based 
on business operations.  
 
2.3 DATA CAPTURE 
 
A data capture sheet (Appendix B) was used to collect the following data: clinic number, age, 
sex, company name, industry type, occupation, exposure agents, intensity and frequency of 
exposure, specific diagnosis and smoking history.  
Additional clinical data, although not specifically recorded on the data capture sheet, were 
available to confirm diagnosis. Such data included spirometry, metacholine challenge test, skin 
prick test, RAST tests, serial peak flow measurements where available, and any supporting 
data to confirm occupational asthma and exclude other conditions.     
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2.4 DATA PROCESSING METHODS AND DATA ANALYSIS  
 
A database was created using Epi Info (version 3.2) statistical software package. The 
researcher captured the data from the data capture sheet. After double entry and verification 
in Epi Info, cleaned data were analysed to address the objectives of the study. All analyses 
were carried out in STATA software version 10. Results were presented using simple 
descriptive statistics. Continuous variables were summarized using means and standard 
deviations. Categorical variables were described using proportions (percentages) and results 
were displayed in tables and graphs. Age was categorised into groups and summarized as 
such.  
To test for statistical difference of summary statistics, chi-square (X2) was used. Mann-U-
Whitney and Kruskal-Wallis tests were used for continuous variables which were not normally 
distributed.  
 
Independent variables used were age, sex, smoking, frequency of exposure, exposure agents 
and industry groups. The outcome variables, latency period and time to diagnosis were 
continuous in time-to-event measured in months. They were described using summary 
statistics and Kaplan-Meier survival curves. To assess crude relationships between the 
independent variables and the study outcomes, bivariate analyses were done using the log-
rank test as a test of equality to assess which of the categorical variables were significant.  
Kaplan-Meier curves of the outcomes were plotted by independent variables to graphically 
display the relationships. 
 
Multivariate analysis: This was a secondary data analysis as such variables were limited to data 
available from the Clinic records. Variables were fitted into the model as they were thought to 
be potential predictors based on literature. Most of the variables were fitted to the model to 
obtain adjusted estimates and to identify important predictors. Occupations were excluded 
because they could not be grouped into meaningful categories due to the varied nature of the 
jobs.  
 
Unadjusted estimates of these important variables are presented in Section 5 before the 
multivariate model.    Two models were constructed for both outcomes.  The final model, Cox 
regression, included most variables. No additional refinement of the model was carried, 
because the size of data was too small to obtain meaningful results.  
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All analyses were carried out at an alpha level of 0.05: p-values less than 0.05 were 
interpreted as statistically significant. Hazard ratios were reported along with their 95% 
confidence intervals. 
 
2.5 ETHICS 
 
Ethical approval was granted by the University of the Witwatersrand Human Research Ethics 
Committee (Medical). Ethics approval letter attached (Appendix 3). For confidentiality, codes 
known only to the project manager were used to conceal patient identity; no reference can be 
made to the file or patient. No names or any form of identification are revealed in results or 
any published materials. Recommendations will be to individual industries without mention of 
the name of the company but rather a group in which that industry is classified.   
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CHAPTER THREE: RESULTS                               
 
In this chapter, 142 cases of occupational asthma are described. Details of industries, jobs and 
agents implicated in occupational asthma are presented. The 131 cases of sensitizer- induced 
asthma are described separately from the eleven irritant -induced asthma cases. Survival and 
multivariate analysis were performed to test associations between latency period and each 
specific determinant. This has been repeated for time to diagnosis and its determinants. 
Finally, a model using Cox regression was run for both outcomes, namely latency period and 
time to diagnosis. 
 
SECTION 1: DESCRIPTION OF ALL 142 OCCUPATIONAL ASTHMA CASES 
 
Table 1.1 summarises the cases according to general characteristics including the type of 
asthma. In this case series, the majority (82%) of cases were males and just over 40% of 
cases were younger than 40 years with the youngest patient being 25 years old and the eldest 
62 years old. Mean age of both males and females = 43 years. As expected, the majority of 
cases (92%) were sensitizer-induced asthma and most of them were exposed to low- 
molecular weight agents. A quarter of the cases were current smokers and they were all men.
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Table 1.1 Sex, age, smoking status and type of occupational asthma of 142 cases diagnosed 
at NIOH Clinic from 1997 - 2007 
Characteristic Total  
N (%) 
Sensitizer – induced asthma (n =131) 
n (%) 
Sex 
Male  
Female  
Age 
    21- 30 
    31- 40 
    41- 50 
    51- 60 
     60+ 
Smoking status*# 
    Current smoker 
    Non-smoker 
 
Type of asthma 
    Sensitizer 
    Irritant 
 
 
 116 (81.7)     
   26 (18.3) 
 
   14  (9.9) 
    46 (32.4) 
    49 (34.5) 
   31(21.8) 
    2 (1.4) 
 
    36 (26.1) 
   105 (73.9) 
  
     
131 (92.2) 
     11  (7.8) 
 
 
108 (82.4) 
 23 (17.6) 
 
12 (9.2) 
  41 (31.3) 
  46 935.1) 
  30 (22.9) 
  2 (1.5) 
 
 35 (26.7) 
   95 (73.3) 
 
 
 
 
Total     142 (100) 131 (100) 
* The non- smoker category includes ex-smokers and those who never smoked at all. 
# Smoking history is missing for 2 cases.  
 
Somewhat surprisingly, only 14 cases (9.9%) were 30 years or younger; and only 12 cases 
(9.2%) in the sensitizer-induced group. 
 The 142 occupational asthma cases are described below in terms of industry and job. As can 
be seen from Table 1.2, the top five industries, responsible for the majority of occupational 
asthma cases, were Engineering, Chemical, Food, Smelter and Foundry sectors.  
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                                  Table 1.2 Occupational asthma cases by industry 
Industry  N (%) 
Engineering 
Chemical 
Food 
34 (23.9) 
22 (15.5) 
18 (12.7) 
Foundry 16 (11.3) 
Smelter 16 (11.3) 
Transport 8 (5.6) 
Social services 6 (4.2) 
Other manufacturers 6 (4.2) 
Agriculture    4 (2.8) 
Cleaning 4 (2.8) 
Mining 4 (2.8) 
Clay & ceramics        2 (1.4) 
Construction 1 (0.7) 
Power 1 (0.7) 
Total 142 (100) 
 
 
General workers, machine operators and spray painters were the most common job categories 
(Table 1.3). The General workers category consisted of unskilled workers which included 
labourers who worked in a variety of industries. The category of “other” comprised an aircraft 
trimmer, two nurses, a plant sampler and a hairdresser.  
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                          Table 1.3 Occupational asthma cases by type of job  
Type of job N (%) 
General worker      23 (16.2) 
Machine operator    21 (14.8) 
Spray painter       19 (13.4) 
Technical staff    13 (9.2) 
Fitter    11 (7.7) 
Welder      8 (5.6) 
Clerical & sales      7 (4.9) 
Bakery staff          6 (4.2) 
Moulder      6 (4.2) 
Other*      5 (3.5) 
Grinder      4 (2.8) 
Mixer      4 (2.8) 
Building artisan      3 (2.1) 
Core maker           3 (2.1) 
Electrician        3 (2.1) 
Forklift driver      3 (2.1) 
Kiln operator         3 (2.1) 
Total 142 (100) 
*The category “Other” includes nurses (2), aircraft trimmer (1), plant sampler (1) and hairdresser (1). 
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SECTION 2: SENSITIZER-INDUCED ASTHMA CASES 
 
2.1 Industry, type of job and exposure agents for 131 cases of sensitizer-induced 
asthma 
As shown above in Table 1.1, there were 11 cases of irritant- induced asthma. These will be 
described separately in Section 6 at the end of the Results section. The following data are for 
the 131 cases of sensitizer-induced occupational asthma. 
 
Table 2.1 Distribution of 131 cases of sensitizer-induced asthma by industry and agents 
   Industry  Agents     Total 
 Isocyanates Welding Vanadium Wheat Other  
 
Engineering 
 
14 
 
9 
 
0 
 
0 
 
9 
 
32 
Chemical 4 1 0 0 14 19 
Smelter 0 1 15 0 1 17 
Food 0 0 0 9 7 16 
Foundry 2 5 0 0 7 14 
Transport   3 2 0 0 2 7 
Other manufacturer    2 0 0 0 4 6 
Social Services 1 0 0 0 4 5 
Agriculture 0 0 0 0 4 4 
Cleaning   0 0 0 0 4 4 
Mining 0 0 2 0 2 4 
Clay & Ceramics 0 0 0 0 1 1 
Construction   1 0 0 0 0 1 
Power 0 1 0 0 0 1 
Total                         27 19 17 9 59 131 
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According to Table 2.1, the top five industries generating cases were Engineering, Chemical, 
Smelter, Food and Foundry. The majority of cases of isocyanates sensitization came from the 
Engineering sector, followed by Chemical and Transport sectors.  
Cases due to welding came mainly from Engineering and Foundry sectors. Fifteen vanadium 
sensitized cases originated from a vanadium smelter, accounting for the majority of vanadium 
cases in this series. As expected, wheat sensitization mainly occurred in the Food sector. The 
majority of cases in the Food industry came from small-scale bakeries, where they were 
exposed to baking ingredients. 
 
Foundries are better known for silicosis so exposures implicated from foundries need special 
mention. They were chromium salts, formaldehyde, nickel sulphate, resins, isocyanates and 
welding fumes. Cases included in the Social Services category were from a City Council, 
Department of Health, hair salon, technikon and a coin security company. 
The category of “Other” agents was big enough to warrant special mention. Table 2.2 below 
shows these agents by industry. 
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Table 2.2 “Other” agents shown in Table 2.1 by industry  
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Animal feed 1            
Artificial colourants      1       
Chicken litter 2            
Chromium salts  1   1  2      
Cleaning agents  1  3    2     
Cobalt     1        
Colophony  1           
Cooling oils     1        
Formaldehyde     1  1      
Grain dust 1            
Grass           1  
Latex           2  
Leather dust         1    
Methyl Ethyl Ketone*  1          1 
Metal fumes  1           
Milk powder      1       
Nickel sulphate  1     1      
Oil mists     1        
Onion      1       
Paint vapour            1 
Peanuts      1       
Persulphates           1  
Pthallic anhydride  2           
Platinum salts          1   
Polyethylene  1           
Polyvinylchloride  2           
Prepolymer  1           
Proteolytic enzymes  1           
Resins   1  3  3  1    
Rubber     1    1    
Solvents±  1  1  1       
Soybean      2       
Wood dust         1    
TOTAL 4 14 1 4 9 7 7 2 4 1 4 2 
*MEK = Methyl Ethyl Ketone is not an accepted sensitizing agent. Refer to discussion for explanation.  
±Solvents are not established sensitizers but satisfied asthma diagnosis criteria. The two solvents were acetone, 
alkylphenoxy polyethoxyethanol and the third one was referred to only as a solvent. 
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                                  Table 2.3 Type of job for 131 sensitizer-induced asthma cases 
   Type of job n (%) 
General worker 19 (14.5) 
Machine operator             19 (14.5) 
Spray painter                  19 (14.5) 
Fitter    11 (8.4) 
Technical staff                 11 (8.4) 
Welder   8 (6.1) 
Bakery staff   6 (4.6) 
Clerical & Sales   6 (4.6) 
Moulder   6 (4.6) 
Other*   5 (3.8) 
Mixer     4 (3.0) 
Building artisan   3 (2.3) 
Core makers                     3 (2.3) 
Forklift driver                    3 (2.3) 
Grinder                             3 (2.3) 
Kiln operator                     3 (2.3) 
Electrician     2 (1.5) 
Total    131 (100) 
*The job “Other” includes nurses (2), aircraft trimmer (1), plant sampler (1) and hairdresser (1). 
 
Not surprisingly, spray painters were among the commonest categories in this group, and 
coupled with general workers, machine operators, fitters and technical staff, accounted for the 
majority of cases of occupational asthma. The majority of the spray painters (12 of 19) 
originated from the Engineering sector. 
 
Agents causing occupational asthma are generally classified into high molecular weight (HMW) 
and low molecular weight (LMW). In this series, the commonest exposure agents were from 
the low molecular weight category, making up 80.1% of cases. The top three agents were 
isocyanates, welding fumes and vanadium (Table 2.4).  
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Table 2.4 Exposure agents for 131 cases of sensitizer-induced asthma  
       Exposure Agents n (%) 
Low molecular weight agents  
Isocyanates 27 (20.6) 
Welding fumes 19 (14.5) 
Vanadium 17 (12.9) 
Resins   8 (6.1) 
Cleaning agents   6 (4.5) 
Chromium salts        4 (3.1) 
Solvents   3 (2.2) 
Formaldehyde                                    2 (1.5) 
MEK    2 (1.5) 
Nickel sulphate   2 (1.5) 
Phthallic anhydride   2 (1.5) 
Polyvinylchloride   2 (1.5) 
Artificial colourants                 1 (0.8) 
Cobalt   1 (0.8) 
Colophony   1 (0.8) 
Cooling oils   1 (0.8) 
Metal fumes   1 (0.8) 
Oil mists   1 (0.8) 
Paint vapour   1 (0.8) 
Persulphates   1 (0.8) 
Platinum salts   1 (0.8) 
Polyethylene   1 (0.8) 
Prepolymer   1 (0.8) 
  
High molecular weight agents  
Wheat   9 (6.8) 
Chicken litter                            2 (1.5) 
Latex   2 (1.5) 
Rubber   2 (1.5) 
Soybean   2 (1.5) 
Animal feed                      1 (0.8) 
Grain dust   1 (0.8) 
Grass   1 (0.8) 
Leather dust   1 (0.8) 
Milk powder   1 (0.8) 
Onion   1 (0.8) 
Peanuts   1 (0.8) 
Proteolytic enzymes   1 (0.8) 
Wood #   1 (0.8) 
Total 131(100)    
#Wood classified as HMW, although some woods induce asthma by LMW compounds (e.g. plicatic acid in 
red cedar wood).  
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Table 3.1 Latency period by smoking status  
Smoking status Latency period Total Chi-square 
 </= 12 
months 
      > 12 months   
Current smokers 4 (11.4%) 31 (88.6%) 35          χ2 =0.02 
         p-value = 0.55   Non-smokers 10 (10.5%) 85 (89.5%) 95 
  Total 14 116 130*  
      *1 smoking history missing. 
The majority of cases were non- smokers. There were no women current smokers.   
 
Table 3.2 Latency period in years by smoking status 
 N Mean (SD) Median Min - Max Test  
Current Smokers 
Non-smokers 
35 
95 
8.46 (7.54) 
10.37 (8.16) 
6.0 
8.0 
0.1 - 28 
0.1 - 32 
Mann-U- Whitney 
p = 0.202 
  Z = 1.276 
 
Mann Whitney test was used because data is not normally distributed. 
Latency period for current smokers was two years shorter than non-smokers. 
 
Table 3.3 Latency period by high or low molecular weight agent    
Type of Agent Latency period       Total Chi-square 
 
LMW 
</=12 months 
12 (11.4%) 
>12 months 
93 (88.6%) 
 
105 
 
X2 = 0.20 
           p-value = 0.582 HMW         2 (7.7%) 24 (92.3%) 26 
Total 14 117 131  
 
The majority of cases in both categories (HMW and LMW) reported symptoms after the first 
year of exposure. 
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Table 3.4 Latency period in years by type of agent (high versus low molecular weight) 
 N Mean (SD) Median Min - Max Test    
LMW 
HMW 
105 
26 
9.94 (8.12) 
9.42 (7.52) 
8.0 
7.0 
0.1 – 32 
0.1 - 27 
Mann-U-Whitney 
p =0.869 
Z =0.165 
   
 
Data not normally distributed so Mann Whitney test used. 
 
The type of exposure agent has been reported as a factor in determining time to symptom 
development. Although not statistically significant,  the latency period, that is, time from first 
exposure to development of symptoms, people exposed to HMW agents reported symptoms 1 
year earlier than those who were exposed to LMW agents.  
 
 
        Table 3.5 Latency period by four most common agents   
Agent Latency period Total Chi-square 
 </=12 months >12 months   
       χ2 =6.47 
       p-value =0.166 
        DF = 4 
 
Isocyanates   6 (22.2%)* 21 (77.8%)  27    
Welding 0 (0.0%) 19 (100%)  19  
Vanadium 1 (5.9%) 16 (94.1%)  17 
Wheat 1 (11.1%)   8 (88.9%)   9 
Other 6 (10.2%)  53 (89.8%) 59 
Total 14 117 131  
*Row percent 
 
There were no significant differences observed in latency period among various types of 
exposure agents as shown in Table 3.5. However, it is noted that of those exposed to welding 
fumes, none reported symptoms within the first year of exposure.  
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Table 3.6 Latency period in years by four most common agents 
Agent N Mean (SD) Median Min - Max       Kruskal-Wallis  
Isocyanates 27 8.60 (8.15) 7.0 0.1 - 29  
Critical value = 3.009 
            p-value = 0.556 
            
 
 Welding 19 12.26 (9.10) 9.0  3 - 32 
Vanadium 17 9.59 (7.90) 8.0 0.1 – 30 
Wheat 
Other 
9 
59 
11.33 (8.51) 
9.47 (7.55) 
    10.0 
7.0 
  1 - 27 
0.1 - 32 
 
Although there was no statistically significant difference in latency period, isocyanates seemed 
to induce symptoms earlier than the other three most common agents. 
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 Table 4.1 Time to diagnosis by smoking status  
Smoking status Time to diagnosis Total Chi-square 
 </= 12 
months 
      > 12 months   
Current smokers 5 (14.3%) 30 (85.7%) 35       χ2 = 2.07 
      p-value = 0.15 Non-smokers 25 (26.3%) 70 (73.7%) 95 
  Total 30 100 130*  
     *1 smoking history is missing. 
 
A larger, but non-significant, proportion of smokers were diagnosed after having symptoms for 
longer than 12 months (85.7% versus 73.7% in non-smokers).  
 
Table 4.2 Time to diagnosis in years by smoking 
 N Mean (SD) Median Min - Max  Test 
Current Smokers 
Non-smokers 
35 
95 
5.46 (4.16) 
5.03 (5.77) 
4.0 
3.0 
  1 - 15 
0.1 - 32 
 
  
 
Mann –U- Whitney 
           p = 0.151 
           Z = 1.436 
 
 
Table 4.3 Time to diagnosis by high or low molecular weight agent    
Type of Agent Time to diagnosis    Total      Chi-square  
 </=12 > 12 months       χ2 =0.25 
p-value = 0.620 
 
LMW 25 (23.8%) 80 (76.2%) 105 
HMW       5 (19.2%) 21 (84.0%) 26 
Total 30 101 131  
 
Only about 20% of cases in each category were diagnosed within one year of developing 
symptoms. 
 
  37
Table 4.4 Time to diagnosis in years by type of agent (HMW versus LMW) 
 N Mean (SD) Median Min - Max Test  
LMW 
HMW 
105 
26 
5.46 (5.58) 
3.74 (4.14) 
4.0 
2.0 
0.1 – 32 
    0.1 - 18 
Mann-U-Whitney 
P = 0.141 
Z = 1.471 
 
 
On average it took about 5.4 years to get diagnosed for cases exposed to LMW in comparison 
to 3.7 years for HMW. This difference is not statistically significant.  
 
Table 4.5 Time to diagnosis by four most common agents   
Agent Time to diagnosis Total Chi-square 
 </=12 months >12 months   
         χ2 =4.84 
         Df = 4 
        p-value = 0.304 
Isocyanates 7 (25.9%) 20 (74.1%) 27 
Welding 4 (21.0%) 15 ( 79.0) 19 
Vanadium      1 (5.9%)   16 (94.1%) 17 
Wheat      1 (11.1%)  8 (88.9%)  9 
Other 17 (28.8%) 42 (71.2%) 59 
Total 30 101 131  
 
Table 4.6 Time to diagnosis in years by four most common agents 
 N Mean (SD) Median Min - Max  Kruskal-Wallis 
Isocyanates 27 5.66 (5.24) 5.0 0.5 – 23   
   Critical value =4.13 
 
     p-value = 0.388 
Welding 19 4.32 (3.89) 3.0 0.1 - 15 
Vanadium 17 5.53 (2.83) 5.0 1.0 – 10 
Wheat 
Other 
9 
59 
3.60 (2.40) 
5.24 (6.53) 
4.0 
2.0 
     0.2 - 7 
0.1 - 32 
In the table above, the category “other agents” had the shortest time to diagnosis, 2 years, 
and welding fumes followed at 3 years in comparison to the other three most common agents. 
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SECTION 5: SURVIVAL AND MULTIVARIATE ANALYSIS 
 
In this section, two multivariate analyses are presented for sensitizer-induced asthma cases. 
Independent variables used were age, sex, smoking, frequency of exposure, exposure agents 
and industry groups. The outcome variable, latency period was continuous in months. The 
same method was employed for time to diagnosis. 
 
First, latency period analysis is presented followed by time to diagnosis analysis. The individual 
independent variables that were included in the models were age at exposure, sex and 
smoking; and occupational determinants were frequency of exposure, exposure agents and 
industry category. Crude bivariate analyses were done for each categorical determinant. Then 
the log-rank test was used as a test of equality to see which of the categorical variables were 
significant. Kaplan-Meier curves were plotted by independent variables. The final model, Cox 
regression included most variables listed above.  
 
Below, all variables, including those that did not show significant associations, are described by 
graph and table. These determinants are age, sex, smoking, frequency of exposure, exposure 
agent and industry. And the final model is presented showing all variables, hazard ratios and 
confidence intervals.  
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5.1 Latency period 
 
Note: only 129 cases are included in the analysis because of missing information for two 
records without date on when symptoms started.  
 
 
 
Figure 5.1.1 Latency period failure estimate for all 129 subjects with sensitizer induced 
asthma  
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Age at exposure  
 
Figure 5.1.2 Latency period by age at exposure categorized into 1 </= 30 years and 2 is older 
than 30 years 
 
 
Table 5.1.1 Log-rank test for equality of survivor functions for latency period by 
age at   exposure 
Age at exposure (yrs) Events 
 Observed Expected 
</= 30 31 12.54 
   > 30 98 116.46 
Total 129 129 
 
                                       chi2 (1) =      35.13 
                                       Pr>chi2 =     0.0000 
 
Younger people had a significantly shorter latency period, suggesting that they reported 
developing symptoms sooner after exposure than older people. 
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Sex 
 
 Figure 5.1.3 Latency period by sex 
 
 
             Table 5.1.2 Log-rank test for equality of survivor functions for latency period by sex  
    Sex                                                   Events 
                            Observed Expected 
Females                            23                               28.78 
Males                              106                               100.11 
Total  129 129.00 
 
                                  chi2 (1) =       1.73 
                                  Pr>chi2 =     0.1879 
 
Although not statistically significant, our data shows that men reported developing symptoms 
earlier than women.  
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Smoking 
 
Figure 5.1.4 Latency period by smoking 
               
 
 Table 5.1.3 Log -rank test for equality of survivor functions for latency period by smoking 
Smoking Events 
 Observed Expected 
Non-smokers 60           63.45 
Current smokers 68            64.55   
Total 128* 128.00 
                  *1 smoking history missing. 
                                            chi2 (1) =       0.41 
                                            Pr>chi2 =     0.5202 
According to figure 5.1.4, current smokers seem to have a shorter latency than non-smokers, 
although this is not significant. 
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Frequency of exposure 
 
Figure 5.1.5 Latency period by frequency of exposure 
 
Table 5.1.4 Log-rank test for equality of survivor functions for latency period by 
frequency of exposure 
Frequency of  
exposure 
Events 
 Observed Expected 
Less frequently 28 31.09 
Daily 101            97.98 
Total 129 129.00 
 
                                     chi2 (1) =       0.43 
                                  Pr>chi2 =     0.5103 
There was no difference between frequency of exposure (those with daily and less than daily) 
and latency period.   
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Exposure agents  
 
Figure 5.1.6 Latency period by type of exposure agent 
 
 
Table 5.1.5 Log-rank test for equality of survivor functions for latency period by 
type of exposure agent 
Exposure agents Events 
 Observed Expected 
Low molecular weight      103         105.62 
High molecular weight        26           23.38 
Total 129 129.00 
 
                                       chi2 (1) = 0.39 
                                       Pr>chi2 = 0.5304 
 
There was no statistical difference in the time taken to report symptoms from the time of first 
exposure to either high or low molecular weight agents. 
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Industry  
 
 Figure 5.1.7 Latency period by type of industry 
  
Table 5.1.6 Log-rank test for equality of survivor functions for latency period by industry type 
Industry Events 
 Observed   Expected 
Engineering 31   34.46 
Chemical 18   10.80 
Smelter 17   16.33 
Food 
Foundry 
16 
14 
  13.85 
  18.28 
Other 33   35.04 
Total 129    129.00 
 
                                           chi2 (4) =     7.32 
                                                    Pr>chi2 =    0.1982 
 
The graph is difficult to interpret visually but clearly people from chemical industry seem to 
report symptoms earlier than those in other industries although this is not statistically 
significant.  
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Multivariate analysis: Cox regression model for latency period 
The variables fitted into this model were decided upon apriori as they were thought to be 
potential predictors based on literature review irrespective of their statistical significance. The 
industry category was further grouped into five most common industry and others. The 
reference industry was the other group. Age at reporting of symptoms was categorised into 
30years and younger or older than 30 years.  
 
All variables were put in the model at the same time without prior adjustment for individual 
variables in other models.  
 
Table 5.1.7 Multivariate analysis: Cox regression model for latency period by chosen variables 
 Variable Hazard ratio p-value 95% conf.  interval 
Sex 
Agents 
Smoking 
1.529 
1.153 
0.960 
0.143 
0.680 
0.856 
( 0.87; 2.70) 
( 0.59; 2.28) 
( 0.62; 1.48) 
Engineering 0.988 0.967 ( 0.57; 1.71) 
Chemical  
Smelter 
Food 
2.032 
1.062 
1.093 
0.029 
0.850 
0.819 
( 1.08; 3.84) 
( 0.57; 1.99) 
(0.51; 2.35) 
Foundry 0.788 0.478 ( 0.48; 1.66) 
Age at symptoms 4.803 0.000 ( 2.47; 9.32) 
Frequency of exposure 1.406 0.146 ( 0.89; 2.23) 
Number of subjects = 128, LR chi2 (10) = 27.26, Log likelihood = -488.26249, Prob > chi2 = 0.0024. 
          
In this model, age at start of symptoms and chemical industry group contributed significantly 
to the model. Cases older than 30 years of age were 4.8 times more likely to report symptoms 
later than younger ones. Cases from the chemical industry group were two times more likely to 
report symptoms earlier in comparison to other industry groups. 
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5.2 Time to diagnosis for selected events 
 
 
Figure 5.2.1 Time to diagnosis failure estimate for all 128 subjects with sensitizer induced 
asthma  
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 Age at diagnosis 
 
Figure 5.2.2 Time to diagnosis by age 
 
Table 5.2.1 Log-rank test for equality of survivor functions for time to 
diagnosis by age at diagnosis 
Age at diagnosis (yrs)  Events 
 Observed Expected 
<= 30 12 1.94 
   >30 119    129.1 
Total 131 131 
 
                                            chi2 (1) =   57.11 
                                           Pr>chi2 =   0.0000 
 
The graph above shows that 100% of young cases were diagnosed within ten years of having 
reported symptoms. This was statistically significant as shown by the p-value less than 0.05  
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Sex 
 
Figure 5.2.3 Time to diagnosis by sex  
 
 
Table 5.2.2 Log-rank test for equality of survivor functions for time to diagnosis 
by sex 
Sex   Events 
 Observed Expected 
Females 23 22.65 
Males 108 108.35 
Total 131 131 
 
                                          chi2 (1) =   0.01 
                                          Pr>chi2 =   0.9331 
 
Although we saw sex differences with regards to latency period, this is not demonstrated for 
time to diagnosis. 
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Smoking 
 
Figure 5.2.4 Time to diagnosis by smoking  
 
 Table 5.2.3 Log-rank test for equality of survivor functions for time to diagnosis   
by smoking  
Smoking   Events 
 Observed Expected 
Current smokers 35 29.18 
Non-smokers 95 100.82 
Total 130* 130.0 
                        *1 smoking history missing. 
                                    
           chi2 (1) =       1.65 
                                        Pr>chi2 =     0.1986 
It looks like it took current smokers slightly less time to be diagnosed as compared to non-
smokers but this is not statistically significant. 
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Frequency of exposure 
 
Figure 5.2.5 Time to diagnosis by frequency of exposure  
 
Table 5.2.4 Log-rank test for equality of survivor functions for time to 
diagnosis by frequency of exposure 
Frequency of 
exposure   
Events 
 Observed Expected 
Less than daily 29 29.56 
Daily 102 101.44 
Total 131 131 
 
                                                chi2 (1) =       0.02 
                                               Pr>chi2 =     0.9025 
 
There is no difference in time to diagnosis between those exposed daily and less frequently. 
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Exposure agents  
 
Figure 5.2.6 Time to diagnosis by type of agent  
 
Table 5.2.5 Log-rank test for equality of survivor functions for time to diagnosis 
by type of exposure agents 
Exposure agents Events 
 Observed Expected 
Low molecular weight         105         110.81 
High molecular weight          26           20.19 
Total 131 131.00 
 
                                 chi2 (1) =   2.17 
                                Pr>chi2 =   0.1412 
 
Cases exposed to high molecular weight agents were diagnosed somewhat earlier than those 
exposed to low molecular weight agents.  
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 Industry 
 
Figure 5.2.7 Time to diagnosis by type of industry 
Table 5.2.6 Log-rank test for equality of survivor functions for time to diagnosis     
by industry type 
Industry Events 
 Observed   Expected 
Engineering 32   32.24 
Chemical 18   13.17 
Smelter 17   16.26 
Food 
Foundry 
16 
14 
  12.30 
  15.43 
Other 34   41.59 
Total 131    131.00 
 
                                       chi2 (5) =    4.84 
                                       Pr>chi2 =   0.4351 
Although it is difficult to interpret the above graph due to 6 industrial groups, cases from the 
chemical industrial group were diagnosed earlier than the other groups. 
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Multivariate analysis: Cox regression model for time to diagnosis 
 
Multivariate model: The variables fitted into this model were decided upon apriori as they were 
thought to be potential predictors based on literature review irrespective of their statistical 
significance. The industry category was further grouped into five most common industry and 
others. The reference industry was the other group. Age at reporting of symptoms was 
categorised into 30years and younger or older than 30 years.  
 
All variables were put in the model at the same time without prior adjustment for individual 
variables in other models.  
 
Table 5.2.7 Multivariate analysis: Cox regression model for time to diagnosis by chosen 
variables 
 Variable Hazard ratio p-value 95% conf.  
interval 
Sex 
Agents 
Smoking 
0.818 
1.631 
0.853 
0.441 
0.170 
0.474 
(0.49; 1.36) 
(0.81; 3.28) 
(0.55; 1.32) 
Engineering 1.625 0.072 (0.96; 2.75) 
Chemical  
Smelter 
Food 
2.124 
1.506 
1.277 
0.020 
0.200 
0.546 
(1.13; 4.00) 
(0.81; 2.82) 
(0.58; 2.82) 
Foundry 1.348 0.380 (0.69; 2.62) 
Age at symptoms 0.095 0.000 (0.05; 0.20) 
Frequency of exposure 1.142 0.557 (0.73; 1.78) 
            Number of subjects = 130, LR chi2 (10) = 38.42, Log likelihood = -491.01462, Prob > chi2= 0.0000. 
                  
In the model, important predictors of early diagnosis were age and chemical industry. People 
younger than 30years of age and those employed in chemical industry were diagnosed earlier. 
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SECTION 6: IRRITANT- INDUCED ASTHMA CASES 
 
Eleven cases satisfied the criteria for irritant – induced asthma as stipulated by Chan- Yeung et 
al.31 Table 6.1 summarises some of the features of these cases.  All cases had no previous 
history of asthma and experienced symptoms within 24 hours of exposure to a high 
concentration of the agent. For those cases that were on treatment and lung function tests 
were within normal limits, the diagnosis was supported by the presence of nonspecific 
bronchial hyper responsiveness. The majority of cases were non-smokers except for 2 current 
smokers and one ex-smoker. A more detailed description of the cases follows.  
 
Table 6.1 Characteristics of irritant-induced asthma cases: sex, age, smoking history, 
type of exposure agent and occupation  
                     
Case   Sex        Age       Smoking status     Type of job                  Agent                    
 
 1       Female      37        Non smoker         Packer                     Cleaning agents                 
 2       Female      34        Non smoker         Off setter                  Methane                           
 3       Male          29        Non smoker         Technician                Hydrofluoric acid               
 4       Male         34         Smoker               Electrician                 Paint vapours                     
 5       Male         45         Non smoker         Cleaner                    Turpentine                          
 6       Male         41         Ex smoker           Brazing                    Acetylene gas                   
 7       Male         39         Non smoker         Technical officer        Irritant gas                        
 8       Male         38         Smoker               Security officer          PVC fumes                        
 9      Female      30         Missing                Secretary                  Diazinon                           
10      Male         42         Non smoker         Packer                      Phosphoric acid                  
11      Male         56         Non smoker         Machine operator       Cyanuric chloride               
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Case 1 involved a one-time high exposure to an unknown irritant cleaning chemical with a 
strong vinegar smell that was used in an adjacent department. Throat and chest symptoms 
were experienced on the same day and were severe enough to warrant a week’s admission to 
hospital. Diagnosis was made several months later because of internal company disputes as to 
the nature of exposure. The case was accepted under COID Act as irritant-induced asthma.   
 
Case 2 also had typical chest symptoms within the same day of exposure to methane and 
other gases due to an electrical fault. She was rushed to hospital after collapsing and not being 
able to breathe. Since then, chest tightness and cough persisted and were aggravated by dust 
at work. She was diagnosed with asthma 3 months after the incident. 
 
Case 3 suffered asthma after inhalation of unusually high amounts of hydrofluoric acid vapor 
and NOX. He had been working in the department for more than 6 years but had never 
experienced exposure to any of the acids as his main duty was welding. The symptoms 
occurred within minutes of him being exposed to the acid mists. He has since been relocated 
and his symptoms have improved. 
 
Case 4 was exposed to isocyanates from paint. He worked as an electrician repairing electrical 
faults in various machines. His company was relocating to new premises. As he walked into the 
new plant he found someone spray- painting a machine in a room where there were no 
extraction fans. The spray-painter had respiratory protection and a face shield but the room 
was covered in a cloud of paint vapour. On that night his chest became tight and he had a 
cough. He consulted his doctor who gave him asthma inhalers which relieved his symptoms. He 
has since been on inhalers and is well controlled except for a few occasions when he is exposed 
to chemicals and heavy smoke. While isocyanates are known sensitizers, they are powerful 
irritants to the mucous membranes and the patient’s clinical presentation favoured irritation 
rather than sensitization.   
 
Case 5, a production process controller was exposed to unusually high levels of an irritant 
known as soft glide. He was opening a bucket to decant the chemical – inhaled the fumes and 
was admitted for chest tightness and wheezing later that day. He was then diagnosed with 
asthma and has been on treatment since then.   
 
Case 6 was exposed to acetylene gas when a cylinder exploded at work. He was admitted to 
ICU the same day and transferred two days later to a general ward. Afterwards, he developed 
recurrent chest tightness, wheezing and voice hoarseness. His work involved brazing copper 
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and zinc metals in an electric motor manufacturing workshop where he is exposed to metal and 
welding fumes. He spent about two weeks per year off work due to asthma attacks.  
 
Case 7 was a technical officer who became symptomatic (cough) 12 hours after having inhaled 
toxic gases whilst fixing cables in a manhole. The unidentified gas smelt like ammonia. The 
following night his cough worsened and he developed chest pain and chest tightness. He was 
given bronchodilators which help improved symptoms but he still remained with nocturnal 
cough and asthma was confirmed by a physician. Two co-workers also developed symptoms 
similar to his.   
 
Case 8 was a man employed as a security officer, deployed to many companies monitoring 
video cameras and patrolling perimeters. A fire broke out in the stores on the night he was at 
work. Exposures included PVC fumes, magnesium, phosphorus, smoke and some gasses 
(possibly acetylene). There were several explosions during the fire. He spent 4 to 5 hours 
fighting the fire (from 09h00 – 14h20). He began feeling unwell, developed a cough and chest 
pain once he had finished fighting the fire. The workplace clinic transferred him to the hospital 
where he was admitted for 2 days. Was told he had asthma and since then, he has been on 
asthma medication, which relieves his symptoms. 
 
Case 9 Her symptoms started within 24 hours of accidental exposure to an agent used for 
spraying pests. The agent’s active ingredient is diazinon and the compound was 64% solvents. 
Her symptoms persisted for more than 3 months and asthma was confirmed by a 
pulmonologist. 
 
Case 10 worked at a chemical manufacturer as a packer. He never suffered from any chest 
problems until after exposure to a mixture of phosphoric and nitric acid after a container fell. 
The vapours were strong but he only started experiencing chest tightness in the evening. He 
received medical attention at the nearby hospital. His symptoms persisted for longer than 3 
months and he has to be maintained on asthma medication. Although his symptoms are milder 
now that he is not exposed and his lung functions are within normal limits, metacholine 
challenge test confirmed the presence of moderate bronchial hyper responsiveness. 
 
Case 11 experienced chest tightness immediately after heavy exposure to cyanuric chloride, a 
known corrosive and irritant to mucous membranes. He consulted a doctor who prescribed 
“pumps” which relieve the symptoms. His symptoms persisted and were triggered by exposure 
to cyanuric chloride. Since he has been relocated, his asthma is controlled.  
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CHAPTER FOUR: DISCUSSION 
 
This review of asthma referrals to the NIOH Occupational Medicine Clinic has highlighted 
causative industries and identified exposure agents implicated in cases of occupational asthma. 
The very wide range of industries, occupations and agents associated with these cases is 
suggestive of a wide-spread occupational asthma problem in the region referring cases to the 
Clinic. The long latency period: mean of 9.8 years and a median of seven years, was 
surprising. The delay in diagnosis (mean of 4.9 years and median of three years) is of concern 
since prompt diagnosis and removal from exposure are associated with better prognosis.  
Younger cases had a shorter latency period and a longer delay in diagnosis. Irritant-induced 
asthma is infrequently reported in the local literature, but the range of agents and jobs is 
possibly indicative of under-diagnosis.    
Our findings are subject to several limitations. The main limitation of this study is limited 
representativeness of cases. Cases in this series came from a variety of industries but there 
are industries whose exposures are important in occupational asthma that are not within the 
vicinity of the NIOH e.g., platinum refining. Additionally, some cases of occupational asthma 
from industries with good occupational health services may have been diagnosed without being 
assessed at NIOH. As such, cases from these industries would rarely present to the NIOH 
Clinic. The NIOH Clinic is a referral clinic, so the patient population does not represent workers 
in the community because they first had to consult a GP or another medical practitioner who 
made a decision whether to refer or not. Also, the NIOH Clinic’s database may have been 
incomplete and some cases may have been missed resulting in incomplete description of 
industries and agents. However, for those cases that were included in this study, there is 
evidence of consistency with other studies in terms of common occupational asthma causing 
agents.67 Consequently, the results are still valuable in having identified common agents, 
occupations and industries implicated in occupational asthma in the catchment area, therefore, 
making it possible to  target prevention.   
 
Significant misclassification of diagnosis of occupational asthma is unlikely in this series. 
Although specific inhalation tests (considered as the gold standard for diagnosis of occupational 
asthma) were not performed in all these cases, objective evidence of asthma was verified in all 
cases. Cases selected were assessed by doctors experienced in occupational medicine and were 
all accepted by the Compensation Commissioner as occupational asthma so diagnosis was 
likely to be reliable in the vast majority. However, some cases did not have objective evidence 
of sensitization because standardized methods are lacking for many occupational agents like 
vanadium. Over the years, different doctors have used different criteria for confirmation of 
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occupational asthma diagnosis, introducing some subjectivity in case selection for the series. 
Some cases included here were exposed to known irritants or triggers, e.g. solvents, but did 
not have any other known exposure so they were accepted as cases of occupational asthma.  
 
Although unlikely, it is possible that there are some cases of occupational asthma that were 
misclassified as not being occupational asthma and therefore, not included in this analysis. 
However, given the Clinic’s interest in occupational asthma and vigorous work-up of cases, the 
number misclassified is likely to be small.   
 
Being a retrospective record review, this series poses some limitations in terms of size and 
accuracy of data.  This data set was small with limited number of variables per subject so it 
limited analysis. Data were not collected with this study in mind, so information from the 
medical records was not organized in a standardized manner, making it difficult to extract 
some data. For example, job descriptions were not standardized so a system had to be 
implemented in order to categorise jobs into standard job categories. A standardized industry 
list from the Compensation Fund was used as a reference for categorizing industries. 88 
Although this list has helped in limiting misclassification of job and industry categories, some of 
the classifications were broad, e.g. “Chemical”, and were poorly descriptive of the actual nature 
of the industry. “Chemical” does not only refer to a big chemical manufacturer but 
encompasses even a small enterprise whose processes are very different from the bigger 
enterprise.  
 
4.1 SENSITIZER-INDUCED ASTHMA CASES 
 
4.1.1 Causative agents, common industries and occupations 
 
Although there are more than 300 agents known to cause occupational asthma, there are a few 
that are known to be common across countries. Comparing the ten most common agents in 
South Africa and other parts of the world with those in this series, there is consistency even 
though the order might not be the same.1, 66, 81, 89, 90 
 
In this series, isocyanates were prominent, followed by welding fumes, vanadium and wheat. 
Isocyanates are still the single largest cause of occupational asthma in many countries. 
Isocyanates were still frequently identified in this case series. The majority of workers exposed 
in this series were spray painters in panel-beating shops. Thus there is little evidence that 
strategies for prevention and control have been implemented. Targeted intervention strategies 
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are probably warranted. The industry is large but generally well organized so targeted 
prevention is possible. Interventions to control exposure to isocyanates have been proposed by 
the Health and Safety Executive – UK and need to be considered in South Africa. These will 
include, amongst others, proper design, application and use of spray booths and rooms; and 
following correct working procedures.7 
 
Welding of specific metals like nickel, zinc, stainless steel, particularly those with high 
chromium content, are established causes of occupational asthma.91 Information on the type of 
welding and the metal used in welding was incomplete from the records so it was difficult to 
categorise welders in terms of their specific exposure agents, hence all were classified as being 
exposed to welding fumes. Nonetheless, even if it may have added value to identify specific 
agents, recommending general control measures should still be beneficial in the prevention of 
asthma in welders.  
 
Vanadium is not universally accepted as a cause of occupational asthma. However, it has been 
reported to induce bronchial hyper responsiveness and asthma in those workers exposed to 
vanadium pentoxide who previously had normal lung functions.81 Vanadium was the third most 
common agent in this series. All these cases arose from one smelter. This issue calls for further 
research in the mechanism of causality, diagnosis, tests of sensitization and intervention 
strategies to control exposure.   
 
Wheat and other baking ingredients have been ranked high among asthma causing agents in 
most surveillance data in many countries.58, 92, 93 It is not surprising that it was one of the four 
most common agents in this series. Some cases were sensitized to more than one baking 
ingredients. Other responsible agents were rye, alpha amylase, soya, buckwheat, etc. The 
majority of cases of wheat sensitization came from small-scale bakeries in supermarkets. 
Targeted intervention is feasible as these bakeries fall under the same employer and guidelines 
have been formulated.94  
 
Latex has been amongst the commonest agents causing occupational asthma in South Africa in 
the early 2000’s.66, 95 The incidence of Latex induced occupational asthma has been decreasing 
since around 1997, mainly due to greater awareness of the problem and replacement of 
disposable natural rubber latex gloves with powder free or nitrile (latex free) gloves.96 In this 
series, there were only two cases of latex allergy. This might be a true reduction in the number 
of latex allergy cases following substitution of latex in health care and the use of powder-free 
gloves as it happened in the UK.49 On the other hand, this might be a confirmation that this 
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series is not representative of occupational asthma agents in South Africa; which is also 
confirmed by the absence of other common agents like platinum salts, resulting in platinum 
salt sensitivity, a common condition in the mining sector.80 Cases of platinum salt sensitivity 
would have been referred to various mining occupational health services and would not be 
assessed at the NIOH.  
 
Occupational asthma can be caused or associated with agents that are not found on common 
lists and databases. An example is cleaning agents. There is growing evidence that cleaning 
agents, previously not known to cause sensitizer-induced asthma, are now being recognized as 
established causes of asthma.97 Thus each suspected case warrants thorough exploration of 
occupational, symptom and exposure histories. However, fugitive exposures have to be 
excluded or identified. Although there were no specific cleaning agents identified in the cases in 
this series, it can be assumed that they caused occupational asthma owing to work-relatedness 
of their condition with no evidence of pre-existing asthma. The relative constituents need to be 
identified to identify the sensitizing agent in these products. This is important not only in the 
holistic management of asthma but also in advising manufacturers of the offending agent for 
control purposes because cleaning is a large industry employing a growing number of 
employees.   
 
Methyl Ethyl Ketone (MEK) and other solvents need special mention because they are not 
generally accepted as causes of sensitizer-induced occupational asthma. Some sensitizers are 
also irritants, e.g. isocyanates. However, these specific solvents have not been generally 
accepted as sensitizers. MEK is a solvent with irritant properties so the mechanism of inducing 
asthma could have been of long term low irritant exposure. The two cases were included in this 
series because: they had no previous history or diagnosis of asthma; asthma symptoms 
started after being exposed to MEK and when not working with MEK, asthma symptoms 
subsided; no other agents known to cause asthma were identified amongst workplace 
exposures and; the cases were accepted and awarded compensation as cases of occupational 
asthma. The reason for being implicated in the causation of occupational asthma in this series 
was based on chronological occurrence of events and evidence of work-relatedness of 
symptoms in previously healthy individuals. This might have caused a misclassification – cases 
exposed to solvents and MEK specifically may be cases of irritant induced asthma from chronic 
exposure to low levels of irritants, an entity not yet widely accepted, or adult- onset asthma 
triggered by exposure. 
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Unexpectedly, wood dust was not common in this series probably due to selection bias: not all 
industries refer their patients to the NIOH and those within the NIOH catchment area mainly 
consist of Engineering, Chemical, Food, Foundry and Smelter industries. The construction 
industry, where most cases of wood dust exposure would come from 98 although large in South 
Africa, is poorly served by occupational health services and it can be reasonably assumed that 
this large sector was under-represented in this series. 
  
The five common industries associated with work-related asthma in developing countries are 
manufacturing; health care; agriculture, forestry and fishing; service work (cleaners, etc); and 
mining (refinery).1 Industries that accounted for the majority of cases of occupational asthma 
in this series were Engineering, Chemical, Smelter, Food and Foundry sectors. Engineering is 
largely made up of manufacturing and the majority of cases in the Food industry category were 
bakers. Geographical differences account for the paucity of cases of occupational asthma from 
the agriculture, forestry and fishing industries in this series. These industries are not common 
in the NIOH catchment area. 
 
The most common occupations were general workers, machine operators in different industries 
and spray painters, mainly from autobody repairers (panel beating shops). Asthma-causing 
agents occur in a variety of industries and can affect individuals in many occupations in these 
industries. Machine operators are too general a group to target prevention so each industry has 
to look at their labour force to check for specific exposures encountered in each group. General 
workers work all over the factory, as a result, can be exposed to a variety of agents. There is a 
need to carefully identify specific agents each group is exposed to and include them in 
preventive strategies for each department.   
 
4.1.2 Age, smoking and sex differences 
 
Age was categorised into either younger or older than 30 years.  There were differences 
between the age groups in latency to reporting symptoms and in the time it took for cases to 
be diagnosed. Younger people reported symptoms sooner and it took the majority of them less 
than 12 months to be diagnosed. The reasons for this finding are uncertain although older 
people might attribute their illness to ageing and may therefore be less likely to seek medical 
help. 
 
Smokers accounted for 26.7% of the cases of sensitizer-induced asthma. Cases who were 
current smokers at the time of exposure, developed symptoms 2 yrs earlier than non-smokers; 
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and it took them one year longer to be diagnosed following onset of symptoms. It is 
questionable as to whether the delay in diagnosis was as a result of smoking or not. Smokers 
might have not attributed their symptoms to workplace exposures but rather to smoking hence 
it took them a little bit longer to be diagnosed. The relationship between smoking and 
occupational asthma still needs further research because the current evidence is controversial 
and sometimes contradictory.99 The recent study by Nielsen et al. suggests that the effect of 
smoking on occupational asthma depends on the type of allergen rather than atopy status of 
the individual.100  
 
Although one would not expect differences in response to sensitizing agents in different sexes, 
there are sex differences in patterns of employment and health seeking behavior. Men tend to 
delay seeking health care and present to health care facilities less frequently than women.101 
In this analysis; we used sex to examine for these differences. Although not statistically 
significant, our data showed that men reported symptoms earlier than women. In general 
women would seek health care more than men. The difference in this series might be explained 
by the fact that women might have worked in low category occupations in industries without 
occupational health services, restricting their geographical and financial access to health care.  
 
4.1.3 Latency period  
 
Latency period in this series is taken as the time from exposure to development of symptoms. 
There can be a very long time between exposure and development of symptoms.102 A study by 
Smith103 describing latency period in bakers reported the mean latency period of 7.3 years 
with three of the 90 employees reporting symptoms in the first year of exposure. The longest 
latency period was 26 years. The latency period for this series was similar. It ranged from one 
month to 32 years with a median of seven years.  Over half of the cases (80) reported 
developing symptoms in the first ten years of exposure with the majority thereof (48) reporting 
them in the first five years. Warren et al.104 predicted a mean latency period for respiratory 
symptoms to be 10.3 years. Other studies80 have reported a high proportion of cases getting 
symptoms within the first two years.  
 
Latency period according to type of agent did not vary much between low molecular and high 
molecular weight agents. Isocyanates seemed to induce symptoms earlier than other three 
common agents, with cases exposed to welding fumes showing symptoms some 12 years after 
initial exposure.  
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4.1.4 Time to diagnosis  
 
The long time from reporting development of symptoms to diagnosis is of concern in this 
study. It is expected that most cases will be diagnosed within 12 months after development of 
symptoms if annual surveillance takes place. Possible reasons for delayed diagnosis are 
inadequacy of surveillance in some industries, lack of access to health care, lack of awareness 
of hazards and their health effects on the part of the employee and the attending medical 
practitioner, fear of victimization by employers (hence employees hide symptoms) and general 
acceptance of health effects considered minor by those living in harsher conditions.   
 
The duration of symptoms before diagnosis was the determining factor for severity of asthma 
in some studies. The longer the duration (more than three years), the more severe was the 
asthma.105 In this series, the majority of cases were diagnosed within five years of having 
reported symptoms (median three years). However, it is notable that it took over ten years for 
13 cases to be diagnosed. This is worrisome as the outcome is known to be unfavourable for 
such cases. These 13 cases came from a variety of industries, as such examining the reasons 
for the delay in diagnosis may not be simple, but is worthy of further research.  
 
Of note, there were statistically significant differences between young and old people with 
regards to time to diagnosis. Younger people were diagnosed earlier maybe because they could 
have been more health conscious and presented to health care facilities earlier than older 
individuals.  
 
A larger, but non-significant, proportion of smokers were diagnosed after having symptoms for 
longer than 12 months (85.7% versus 73.7% in non-smokers). Non-smokers were diagnosed 
earlier than smokers. A possible explanation might be that current smokers may not attribute 
their symptoms to workplace exposures, hence they delay seeking medical attention.   
 
On average it took about 5.4 years to get diagnosed for cases exposed to LMW in comparison 
to 3.7 years for HMW agents. This difference is not statistically significant but might be 
explained by differences in distribution between these two agents. There were 105 cases 
exposed to low molecular weight agents versus only 26 exposed to high molecular weight 
agents. 
 
Cases in the Chemical industry were two times more likely to be diagnosed earlier than other 
industries suggesting greater awareness of hazards and disease in this industry. Also some 
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chemical industries are large and thus offer comprehensive occupational health services to 
their employees, possibly including periodic surveillance. 
 
Only age and the Chemical industry were significantly associated with latency period and time 
to diagnosis in the final models. These factors need further structured research using a bigger 
sample size. Campaigns to increase awareness and provide accessible occupational health 
services are needed.   
 
 
4.2 IRRITANT-INDUCED ASTHMA  
 
Studies of the prevalence of irritant-induced asthma have been scarce over the years 
particularly in developing countries. In first world countries, estimated prevalence ranged from 
11 to 15% in the two sentinel projects, namely, the Surveillance of Work-related and 
Occupational Respiratory Disease (SWORD) in the United Kingdom and the Sentinel Event 
Notification System for Occupational Risks in four states in the United States.106, 107 A similar 
prevalence (15%) was reported in Ontario.108 In this series, 11 cases (7.8%) of irritant-
induced asthma were exposed to various respiratory irritants in different industries. The 
prevalence is low but consistent with that of six percent (6%) in other studies using strict 
criteria and definitions for irritant-induced asthma.109, 110 The suggestion is that irritant-
induced asthma is not a common phenomenon.111 In our context, however, lack of recognition 
and under-diagnosis might be plausible reasons for the low prevalence. This calls for 
awareness of the disease and thorough investigation of suspected cases to elicit bronchial 
hyper-responsiveness. 
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CHAPTER FIVE: CONCLUSION AND RECOMMENDATIONS 
 
5.1 CONCLUSION 
 
In conclusion, the majority of cases (131) were as a result of exposure to sensitisers, while the 
remaining cases (11) were due to irritant exposure. Isocyanates and welding fumes were most 
common among low molecular weight agents, with wheat the commonest among high 
molecular weight agents. Key exposure industries were engineering and chemical. Long latency 
and diagnostic lag periods were present among these cases. Age was an important covariate 
for latency and diagnostic lag period.  
 
Despite the limitations of a descriptive study of a selected series of patients, the data 
presented do provide an overview of the wide range of agents, jobs, and industries associated 
with occupational asthma. Data presented here can educate medical practitioners, employers, 
and employees about local risks and can provide basis for a surveillance system, targeted at 
preventing future cases.  
 
 
5.2 RECOMMENDATIONS 
 
The best intervention strategy for occupational diseases including occupational asthma is 
prevention. Strategies for primary and secondary prevention are discussed below.  
 
Primary prevention: Identification of agents commonly causing occupational asthma is the first 
step to prevention. National surveillance schemes are useful in identifying agents, monitoring 
trends, setting priorities for prevention and forming the basis for further research.  
Identified industries (Engineering, Chemical, Smelter, Food and Foundry sectors) need to be 
specifically targeted to assist them in identifying offending agents with the aim of eliminating 
or reducing exposure to those agents. For example, an alternative paint can be substituted for 
the 2-pack isocyanates paint in panel beating shops. If this is not possible, engineering controls 
can be instituted. These can include proper design, application and use of spray booths and 
rooms; and following correct working procedures. Effectiveness of engineering controls should 
be evaluated. Other strategies that are as effective are employee education about hazards and 
social habits like smoking.  
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Secondary prevention: The aim is to detect early signs and symptoms of asthma in workers 
who are potentially at risk so as to avoid further exposure. It is known that asthmatic patients 
who avoid exposure early on in the disease have better prognosis than those who remain 
exposed.29 A structured periodic medical surveillance programme will identify those at risk of 
developing disease. Various tools ranging from symptom questionnaires, spirometry to 
immunological tests are available. These should be used in addition to elimination or reduction 
of exposure. Medical screening alone without exposure control is not effective in preventing 
disease. 
 
Given the weakness of the labour inspectorate and poor coverage of occupational health 
services in South Africa, implementation of recommendations will not be easy. 
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APPENDIX 
 
APPENDIX A 
Steps for data collection 
 
1. Identify all suspected occupational asthma cases from the Clinic’s database (730) 
2. Identify those with confirmed occupational asthma  (157) 
3. Retrieve the medical records of all these cases from the record room 
4. Separate cases into two piles, viz. those satisfying entry criteria and doubtful ones  
                                          (157) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accept as cases 
satisfying entry 
criteria      
 
(140) 
Doubtful cases to be 
reviewed at a clinical meeting 
for consensus decisions  
              
                (17) 
Data capturing 
(142) 
Accept as cases 
Rejected 
(15) 
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APPENDIX B1  
Data capture sheet 
 
OCCUPATIONAL ASTHMA CASES : 1997 ‐ 2007  
1.    CLINIC NUMBER 
     
2.    QUESNO 
  
  
4.   GENDER  Male = 1          Female = 2    
5.   AGE   Years    
6.  CONAME       
7.  INDTYPE       
8.  JOBTYPE       
9.  SYMPT TIME  Months: first exposure to onset of symptoms   
10.  DIAG TIME  Months: first exposure to diagnosis    
11.  SYMPT – DIAG TIME 
Months:  number  of  symptomatic  months  to 
diagnosis 
 
12.   EXPAGENT  Specific name of exposure agent    
13.  FREQEXP 
Daily = 1           Most days = 2     1‐3 days/ week = 3 
Less than 1 day/ week = 4 
  
14. INTEXP 
Low = 1      Medium = 2    High = 3     Medium peak 
= 4 
High Peak = 5       Unable to classify = 6 
 
15.  SMOKE HIST  Smoker = 1       Ex‐Smoker = 2      Non‐Smoker = 3    
16.  PACKYR  Number of cigarettes over 20 by years of smoking    
17.  DIAGNOSIS  OA = 1             IIA = 2                        
18. DATE OF DIAGNOSIS      
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APPENDIX B2  
Explanation of terms on the data capturing sheet  
 
Quesno   = questionnaire number 
 
Age    = age at diagnosis (years) 
 
Coname   = company name 
 
Indtype   = type of industry where exposure occurred 
 
Jobtype   = type of job implicated in exposure 
 
Sympt time (months) = time from first exposure to onset of asthma symptoms  
Diagtime (months)  = time from first exposure to diagnosis of asthma  
Sympt –diag time                = time in months from onset of symptoms of asthma to         
diagnosis   
Expagent   =          type of exposure (specific name of the agent) 
Freqexpo  = Quantification of exposure within a working day or week  
Intexp                                = Intensity of exposure including peak exposures (low,                 
medium, or high     constant exposure; medium or high peaks 
exposure) 
Smoke hist                   = smoking history (ex-smoker = has stopped smoking for 
more          than a year ago) 
Packyr = number of cigarettes smoked per day per duration of 
smoking (N divided by 20, multiplied by duration of smoking in 
years) 
Diagnosis  = occupational asthma (OA) or irritant induced asthma (IIA)       
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